---
title: Acetylcysteine + Arginine + L-Histidine Hydrochloride + Lysine
description: >-
  This combination is prescribed primarily to decrease mucus secretion in
  individuals with lung diseases like bronchitis, asthma, and emphysema. It also
  addresses nutritional deficiencies.  Its pharmacological classifications
  include mucolytic agent and nutritional supplement.
is_banned: false
lastModified: '2025-09-22T17:22:07.715Z'
faqs:
  - q: >-
      What is the recommended dosage for Acetylcysteine + Arginine + L-Histidine
      Hydrochloride + Lysine?**


      **A:**  The standard adult dose is 500 mL infused intravenously over 120
      minutes, with a maximum of 2500 mL daily. Pediatric dosage is not
      established.
    a: >-
      A:**  The standard adult dose is 500 mL infused intravenously over 120
      minutes, with a maximum of 2500 mL daily. Pediatric dosage is not
      established.
  - q: >-
      What are the primary uses of this combination therapy?**


      **A:**  Primarily used to reduce mucus secretion in respiratory conditions
      like bronchitis, asthma, and emphysema, and also address nutritional
      deficiencies.
    a: >-
      A:**  Primarily used to reduce mucus secretion in respiratory conditions
      like bronchitis, asthma, and emphysema, and also address nutritional
      deficiencies.
  - q: >-
      How does acetylcysteine contribute to this combination's therapeutic
      effect?**


      **A:** It acts as a mucolytic, breaking down mucus and making it easier to
      expectorate.
    a: >-
      A:** It acts as a mucolytic, breaking down mucus and making it easier to
      expectorate.
  - q: |-
      What is the role of arginine and lysine in this combination?**

      **A:** They provide nutritional support, being essential amino acids.
    a: 'A:** They provide nutritional support, being essential amino acids.'
  - q: >-
      What are the potential side effects of this intravenous infusion?**


      **A:**  Common side effects include injection site reactions, allergic
      reactions, and bronchospasm. Severe allergic reactions are rare but
      possible.
    a: >-
      A:**  Common side effects include injection site reactions, allergic
      reactions, and bronchospasm. Severe allergic reactions are rare but
      possible.
  - q: >-
      Are there any contraindications for using this combination?**


      **A:** Yes, contraindications include severe hepatic or renal impairment,
      congestive heart failure, severe acidosis, and electrolyte abnormalities.
    a: >-
      A:** Yes, contraindications include severe hepatic or renal impairment,
      congestive heart failure, severe acidosis, and electrolyte abnormalities.
  - q: >-
      What are the key drug interactions to be aware of?**


      **A:** Acetylcysteine has known interactions with several drugs.  It's
      important to check for interactions with any other medications a patient
      is taking.
    a: >-
      A:** Acetylcysteine has known interactions with several drugs.  It's
      important to check for interactions with any other medications a patient
      is taking.
  - q: >-
      Can this infusion be administered to pregnant or breastfeeding women?**


      **A:** Use during pregnancy or breastfeeding should be avoided unless the
      potential benefits clearly outweigh the potential risks.
    a: >-
      A:** Use during pregnancy or breastfeeding should be avoided unless the
      potential benefits clearly outweigh the potential risks.
  - q: >-
      What monitoring parameters should be considered during therapy?**


      **A:**  Respiratory function, liver and kidney function tests, and
      electrolyte levels should be monitored.
    a: >-
      A:**  Respiratory function, liver and kidney function tests, and
      electrolyte levels should be monitored.
  - q: >-
      Is there a specific dosage for clinical situations like intubation or
      mechanical ventilation?**


      **A:** No, dosage in such cases is determined based on the patient's
      individual needs and the specific clinical situation.  Consult a physician
      for specific recommendations.
    a: >-
      A:** No, dosage in such cases is determined based on the patient's
      individual needs and the specific clinical situation.  Consult a physician
      for specific recommendations.
---
## **Usage**

This combination is prescribed primarily to decrease mucus secretion in individuals with lung diseases like bronchitis, asthma, and emphysema. It also addresses nutritional deficiencies.  Its pharmacological classifications include mucolytic agent and nutritional supplement.

Acetylcysteine works by breaking down disulfide bonds in mucus, reducing its viscosity. Arginine and lysine provide nutritional support, while L-histidine, a precursor to histamine, may offer immunomodulatory and antioxidant benefits.


## **Alternate Names**

Aminodrip Infusion (brand name)


## **How It Works**

**Pharmacodynamics:** Acetylcysteine exerts its mucolytic effect by disrupting disulfide bonds in mucoproteins, decreasing viscosity. Arginine and Lysine are essential amino acids involved in protein synthesis and various metabolic processes. L-Histidine is a precursor to histamine, involved in immune regulation and gastric acid secretion.

**Pharmacokinetics:** Acetylcysteine is rapidly absorbed after oral administration. It's metabolized in the liver and excreted primarily in the urine.  Arginine, Lysine, and L-Histidine are absorbed in the small intestine and participate in regular amino acid metabolic pathways. Elimination pathways are primarily renal.


## **Dosage**

### **Standard Dosage**

#### **Adults:**

500 mL infused intravenously over 120 minutes.  A maximum daily dosage of 2500 mL has been reported.


#### **Children:**

Safety and efficacy in children have not been established. Dosage adjustments, if deemed necessary by a physician, would be based on the child's weight and clinical condition.


#### **Special Cases:**

* **Elderly Patients:** A reduced infusion rate is advised.
* **Patients with Renal Impairment:** Dose modification is essential.
* **Patients with Hepatic Dysfunction:** Caution and potential dose adjustment may be necessary.
* **Patients with Comorbid Conditions:** Requires consideration, especially for congestive heart failure or electrolyte imbalances.



### **Clinical Use Cases**

Dosage in clinical settings like intubation, surgical procedures, mechanical ventilation, ICU use, or emergency situations is determined by the specific situation and patient condition. Consult a physician for specific recommendations.

### **Dosage Adjustments**

Adjustments are needed based on renal or hepatic function, age, and other patient-specific factors.



## **Side Effects**


### **Common Side Effects**

Injection site reactions, allergic reactions, bronchospasm.


### **Rare but Serious Side Effects**

Severe allergic reactions (anaphylaxis).


### **Long-Term Effects**

Not well established.

### **Adverse Drug Reactions (ADR)**

Severe allergic reactions requiring immediate medical intervention.



## **Contraindications**

Severe hepatic or renal impairment, congestive heart failure, severe acidosis, electrolyte abnormalities.



## **Drug Interactions**


Acetylcysteine may interact with activated charcoal, antibiotics (azithromycin, chloramphenicol, clarithromycin, etc.), and various other medications. Arginine may interact with antihypertensive medications, nitrates, and sildenafil. L-Histidine and Lysine interactions are less documented but may interfere with certain mineral absorption. Always check for potential interactions with other medications a patient may be taking, including OTC drugs and supplements.  Food and lifestyle factors (e.g., alcohol, smoking) should also be considered.



## **Pregnancy and Breastfeeding**

Use during pregnancy or breastfeeding should be avoided unless benefits outweigh risks, as safety has not been established in these populations.



## **Drug Profile Summary**

* **Mechanism of Action:**  Mucolytic (acetylcysteine), nutritional supplement (arginine, lysine), potential immunomodulatory and antioxidant effects (L-histidine).
* **Side Effects:** Injection site reactions, allergic reactions, bronchospasm.
* **Contraindications:** Severe hepatic or renal impairment, congestive heart failure, severe acidosis, electrolyte abnormalities.
* **Drug Interactions:** Refer to the Drug Interactions section.
* **Pregnancy & Breastfeeding:** Avoid unless benefits outweigh risks.
* **Dosage:**  Refer to the Dosage section.
* **Monitoring Parameters:** Respiratory function, liver and kidney function tests, electrolyte levels.


## **Popular Combinations**

Combinations with other respiratory medications (e.g., bronchodilators, corticosteroids) may be used in clinical practice based on the patient's specific respiratory condition.


## **Precautions**


Pre-screening for allergies, metabolic disorders, organ dysfunction is necessary. Specific precautions are needed for pregnant or breastfeeding women, children, elderly patients, and those with comorbid conditions.  Lifestyle considerations such as alcohol consumption and smoking should be assessed.



## **FAQs (Frequently Asked Questions)**

### **Q1: What is the recommended dosage for Acetylcysteine + Arginine + L-Histidine Hydrochloride + Lysine?**

**A:**  The standard adult dose is 500 mL infused intravenously over 120 minutes, with a maximum of 2500 mL daily. Pediatric dosage is not established.

### **Q2: What are the primary uses of this combination therapy?**

**A:**  Primarily used to reduce mucus secretion in respiratory conditions like bronchitis, asthma, and emphysema, and also address nutritional deficiencies.

### **Q3: How does acetylcysteine contribute to this combination's therapeutic effect?**

**A:** It acts as a mucolytic, breaking down mucus and making it easier to expectorate.

### **Q4: What is the role of arginine and lysine in this combination?**

**A:** They provide nutritional support, being essential amino acids.

### **Q5: What are the potential side effects of this intravenous infusion?**

**A:**  Common side effects include injection site reactions, allergic reactions, and bronchospasm. Severe allergic reactions are rare but possible.

### **Q6: Are there any contraindications for using this combination?**

**A:** Yes, contraindications include severe hepatic or renal impairment, congestive heart failure, severe acidosis, and electrolyte abnormalities.

### **Q7: What are the key drug interactions to be aware of?**

**A:** Acetylcysteine has known interactions with several drugs.  It's important to check for interactions with any other medications a patient is taking.

### **Q8:  Can this infusion be administered to pregnant or breastfeeding women?**

**A:** Use during pregnancy or breastfeeding should be avoided unless the potential benefits clearly outweigh the potential risks.

### **Q9: What monitoring parameters should be considered during therapy?**

**A:**  Respiratory function, liver and kidney function tests, and electrolyte levels should be monitored.

### **Q10:  Is there a specific dosage for clinical situations like intubation or mechanical ventilation?**

**A:** No, dosage in such cases is determined based on the patient's individual needs and the specific clinical situation.  Consult a physician for specific recommendations.

